“IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?” (2017) Mediterranean Journal of Hematology and Infectious Diseases, 9(1), p. e2017010. doi:10.4084/mjhid.2017.010.